◼ Archived
Health
New Pancreatic Cancer Vaccine Sparked Immune Responses in 99% of Patients
An experimental mRNA vaccine targeting KRAS mutations triggered immune responses in 99% of pancreatic cancer patients in recent Phase 2 study results.